|
Volumn 92, Issue 6, 2009, Pages 2082-2084
|
Minimal stimulation using gonadotropin-releasing hormone (GnRH) antagonist and recombinant human follicle-stimulating hormone versus GnRH antagonist multiple-dose protocol in low responders undergoing in vitro fertilization/intracytoplasmic sperm injection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CETRORELIX;
PROGESTERONE;
RECOMBINANT CHORIONIC GONADOTROPIN;
RECOMBINANT FOLLITROPIN;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DRUG EFFICACY;
FEMALE;
FEMALE INFERTILITY;
FERTILIZATION IN VITRO;
HUMAN;
INFERTILITY THERAPY;
INTRACYTOPLASMIC SPERM INJECTION;
MAJOR CLINICAL STUDY;
OOCYTE DONATION;
OVARIAN STIMULATION;
OVARY FOLLICLE MATURATION;
PREGNANCY RATE;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT RESPONSE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FERTILIZATION IN VITRO;
FOLLICLE STIMULATING HORMONE;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
OOCYTE RETRIEVAL;
OVULATION INDUCTION;
PREGNANCY;
PREGNANCY RATE;
PROSPECTIVE STUDIES;
RECOMBINANT PROTEINS;
SPERM INJECTIONS, INTRACYTOPLASMIC;
|
EID: 70949086329
PISSN: 00150282
EISSN: None
Source Type: Journal
DOI: 10.1016/j.fertnstert.2009.06.005 Document Type: Article |
Times cited : (35)
|
References (6)
|